Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population. [electronic resource]
Producer: 20101102Description: 696-704 p. digitalISSN:- 1540-8159
- Aged
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Cardiomyopathies -- drug therapy
- Death, Sudden, Cardiac -- prevention & control
- Defibrillators, Implantable
- Female
- Follow-Up Studies
- Heart Failure -- drug therapy
- Humans
- Male
- Middle Aged
- Receptors, Angiotensin -- drug effects
- Stroke Volume -- drug effects
- Tachycardia, Ventricular -- therapy
- Treatment Outcome
- Ventricular Dysfunction, Left -- drug therapy
- Ventricular Fibrillation -- therapy
- Ventricular Function, Left -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.